Self-assembled multifunctional nanotheranostics loading GEM for targeted lung cancer therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Lung cancer remains a leading cause of cancer-related mortality worldwide.
• Effective drug delivery and imaging are crucial for improving lung cancer treatment outcomes.
• Targeted therapies and advanced imaging modalities offer potential for enhanced therapeutic efficacy.

Purpose of the Study:

• To design and evaluate novel self-assembly nanoparticles for MRI-guided lung cancer therapy.
• To incorporate gemcitabine (GEM) as a chemotherapeutic agent.
• To utilize anti-Epidermal Growth Factor Receptor (anti-EGFR) for targeted delivery and imaging.

Main Methods:

• Preparation of self-assembly nanoparticles (SDP-GEM/PEI-PEG-anti-EGFR) encapsulating gemcitabine.
• Evaluation of imaging capabilities using Magnetic Resonance Imaging (MRI) under T2-weighted imaging (T2WI).
• Assessment of targeting feasibility, in vitro cytotoxicity, and in vivo anti-tumor efficacy.

Main Results:

• SDP-GEM/PEI-PEG-anti-EGFR nanoparticles demonstrated contrast enhancement in T2WI with a concentration-dependent relationship to relaxation rates (R2 and R2*).
• Targeting with anti-EGFR significantly increased nanoparticle endocytosis, leading to effective in vitro killing of lung cancer cells.
• In vivo studies showed accurate tumor site delivery within 3 hours, prolonged circulation time, reduced tumor volume, and efficient tumor growth inhibition.

Conclusions:

• SDP-GEM/PEI-PEG-anti-EGFR nanoparticles represent a promising, safe, and effective drug carrier for lung cancer.
• The developed system integrates chemotherapy, MRI guidance, and targeted delivery for enhanced therapeutic potential.
• This approach holds significant promise for advancing MRI-guided lung cancer therapy.